GHRP-6

What Is GHRP-6?

GHRP-6 (Growth Hormone Releasing Peptide-6) is a synthetic peptide composed of 6 amino acids and one of the earliest growth hormone secretagogues developed, derived from chemical modifications of met-enkephalin. As a research compound, it has attracted significant scientific interest for its potent growth hormone-releasing and ghrelin-mimetic properties, extensively documented in preclinical and clinical research models.

Its underlying biological role relates to activation of the growth hormone secretagogue receptor (GHS-R1a) — the receptor through which the endogenous hormone ghrelin acts. GHRP-6 was pivotal in the discovery of this receptor, predicting the existence of ghrelin years before it was isolated (Howard et al., 1996; Kojima et al., 1999). Studies indicate that GHRP-6 stimulates pulsatile growth hormone (GH) release from the pituitary, drives appetite signaling, and influences pathways related to cardiac and tissue protection (Bowers et al., 1984).

Mechanism of Action

GHRP-6 is studied for its dual action on the hypothalamus and the anterior pituitary, binding GHS-R1a to amplify natural pulsatile GH secretion through Gq/11 signaling, PLC activation, and intracellular calcium release (Smith et al., 1996; Hataya et al., 2001). It also acts synergistically with growth hormone-releasing hormone (GHRH), producing greater combined GH output than either peptide alone.

Key Areas of Research

Growth Hormone & IGF-1 Stimulation

Preclinical and clinical studies show consistent, dose-dependent increases in serum GH and IGF-1 following GHRP-6 administration, with synergistic effects when co-administered with GHRH (Bowers et al., 1991).

Appetite & Ghrelin Signaling

Research highlights GHRP-6 as one of the most potent appetite-stimulating GHRPs, with documented increases in food intake — making it a key tool in cachexia, anorexia, and metabolic research models (Laferrère et al., 2005).

Cardioprotection & Tissue Repair

Preclinical models report reduced myocardial infarct size, improved cardiomyocyte survival, and enhanced wound and scar healing through GHS-R-mediated pathways (Berlanga et al., 2007; Cibrián et al., 2006).

Neuroprotection & Sleep Research

Studies highlight effects on slow-wave sleep architecture, memory-related signaling, and neuronal survival pathways relevant to neurodegenerative research (Frieboes et al., 1995).

Research Use Only

GHRP-6 supplied by Peptidos.eu is intended exclusively for laboratory and scientific research. It is not approved for human or animal consumption and must not be used as a medicine or diagnostic tool.

Disclaimer

The products offered by peptidos.eu are intended exclusively for research and laboratory use and are sold only to qualified professionals, institutions, or authorized entities. These products are not intended for human or veterinary consumption, nor for any application involving living organisms, including — but not limited to — diagnostic, therapeutic, or recreational purposes.

By Making a Purchase, the Customer Declares that:

• They are a qualified professional or entity, possessing the necessary competence, training, and facilities for the safe handling of chemical reagents;

• They will use the product in full compliance with all applicable local, national, and European Union laws and regulations;

• They will adopt appropriate safety measures during all stages of handling, storage, and disposal.

Prohibited Uses

• The product must not be used as an Active Pharmaceutical Ingredient (API) in the manufacturing or preparation of medicines intended for humans or animals;

• Any direct administration or use on humans or animals is strictly prohibited;

• Peptidos.eu does not endorse or permit the use of its products for the production, testing, or development of illegal substances.

Liability

• The purchaser assumes full responsibility for the handling, storage, and use of the product in safe conditions and in compliance with the law.

• Peptidos.eu shall not be held liable for any direct or indirect damages arising from improper use, incorrect storage, or unauthorized use of the product.

• Peptidos.eu reserves the right to refuse the sale to any individual or entity suspected of improper use of its products.

• In case of doubts regarding the safe and lawful use of the product, it is recommended to consult a qualified professional experienced in laboratory research.

Regulatory Compliance

Peptidos.eu does not claim or imply that its products are approved by the European Medicines Agency (EMA), the Food and Drug Administration (FDA), or any other regulatory authority. All information provided is for informational and scientific purposes only. These products are not intended to diagnose, treat, cure, or prevent any disease.